Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum.

Journal of Clinical Microbiology
M VaneechoutteA M van den Abeele

Abstract

Nonselective media and previously described selective media were used to study the occurrence of Moraxella (Branhamella) catarrhalis in sputum samples of good and poor quality and in samples taken from different sites of the upper respiratory tracts of healthy subjects. It was found that in healthy adults the carrier rate was 5.4%, as opposed to 50.8% in children and 26.5% in people older than 60 years. M. catarrhalis was recovered significantly more often from sputum samples of good quality (5%) than from poor quality samples (0.5%), and when present, it was found mostly in the presence of high inocula. From these data gathered from healthy and diseased subjects, it is concluded that the presence of M. catarrhalis in the sputum of adults is rarely due to oronasopharyngeal contamination of the sputum. Similar findings reported by others are discussed, and the origins of the currently held concept that M. catarrhalis is a common commensal organism of the human upper respiratory tract are traced.

References

Jul 16, 1977·Lancet·G NinaneM Kraytman
Jan 1, 1976·Annual Review of Microbiology·S D Henriksen
Apr 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H Schønheyder, T Ejlertsen
Mar 1, 1985·The Journal of Hospital Infection·F AhmadM A Calder
Jun 1, 1988·Journal of Clinical Microbiology·M VaneechoutteP Flamen
Dec 1, 1988·Journal of Clinical Microbiology·M VaneechoutteA M van den Abeele
May 1, 1988·Journal of Clinical Microbiology·J S Knapp, E W Hook
Oct 1, 1986·European Journal of Clinical Microbiology·I EliassonK Prellner
Jan 1, 1987·Reviews of Infectious Diseases·G F Van HareC H Kim
Mar 1, 1986·Diagnostic Microbiology and Infectious Disease·G V Doern
Sep 1, 1983·Infection and Immunity·S S LongK L McGowan
Feb 1, 1980·Journal of Clinical Microbiology·G V Doern, S A Morse
Jan 1, 1980·Scandinavian Journal of Infectious Diseases·L SchalénC Schalén
May 1, 1981·American Journal of Clinical Pathology·D A Herbert, J Ruskin
Sep 1, 1980·Acta Oto-laryngologica·A B LaurellK Prellner
Sep 1, 1981·Southern Medical Journal·A von Graevenitz, R R Rathbone
Jan 1, 1981·Scandinavian Journal of Infectious Diseases·J E Brorson, B E Malmvall

❮ Previous
Next ❯

Citations

Jun 15, 2011·Microbiology and Immunology·Hironori MasakiHiroshi Watanabe
Jan 9, 2018·Seminars in Ophthalmology·Yui TobimatsuSatoru Yamagami
Jan 1, 1995·Infection·J KellensE Stobberingh
Aug 26, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K McGregorT V Riley
Mar 14, 2003·The Pediatric Infectious Disease Journal·Patricia Stutzmann MeierChristoph Aebi
Apr 29, 2006·Current Infectious Disease Reports·Larry Lutwick, Laila Fernandes
Apr 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M G MorganF X Emmanuel
Jan 1, 1994·Scandinavian Journal of Infectious Diseases·P Gottfarb, A Brauner
May 23, 2003·Current Infectious Disease Reports·Nargis NaheedLarry I. Lutwick
Mar 1, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·M RahmanA Krook
Aug 17, 2019·Journal of Medical Microbiology·Abigail L CoughtrieStuart C Clarke
Apr 5, 2005·American Journal of Respiratory and Critical Care Medicine·Timothy F MurphySanjay Sethi
Jan 1, 1993·Scandinavian Journal of Infectious Diseases·J DarelidB E Malmvall
Mar 8, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yali LiuHui Wang
Apr 7, 2019·International Urology and Nephrology·Mehmet Sarier, Erdal Kukul
Nov 26, 2003·Infection and Immunity·Patricia Stutzmann MeierChristoph Aebi
Feb 15, 2013·American Journal of Rhinology & Allergy·Brad A RawlingsJoseph K Han
Jun 1, 1995·FEMS Immunology and Medical Microbiology·C HolH van Dijk
Sep 18, 2018·Cornea·Hamza ZafarFiona Carley
Dec 26, 2001·The Journal of Laboratory and Clinical Medicine·S DudleyJ O Hendley
May 1, 1995·Clinical and Diagnostic Laboratory Immunology·C M VerduinH Van Dijk
Jan 1, 1995·Clinical and Diagnostic Laboratory Immunology·J J ChristensenA Forsgren
May 1, 1996·Clinical and Diagnostic Laboratory Immunology·K OishiK Matsumoto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.